Hunis, Narcisa .
HRN: 23-35-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/23/2026
03/30/2026
IV
600mg
Q6
Infected Wound 600mg IV (4ml) 1 Amp X 3doses Per Day X 7 Days = 21 Amps/quantity
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines